In 2000, the UN defined a set of goals on which a global political consensus was reached -- the 'Millennium Development Goals' (1,2). The fourth goal was defined as an ambition to decrease the levels of global child mortality between 1990 and 2015 by two thirds (3). The leading strategies for achieving child mortality reduction were to implement cost-effective interventions in the largest part of the population in low and middle income countries (4-7). These interventions were developed to prevent and treat the leading causes of child mortality, eg, preterm birth complications, birth asphyxia, neonatal infections, pneumonia, congenital abnormalities, diarrhoea, tetanus and HIV/AIDS (5,6). Clearly, there are many possible interventions available, and prioritization of those interventions for implementation among children has become one of the most important health policy goals for the governments, especially in low and middle income countries (8). They are calling for better evidence on the efficacy, effectiveness and cost-effectiveness of each intervention, and also better information on the patterns of child mortality burden in their countries (8). Therefore, understanding the causes of child mortality and the effectiveness of the preventive and treatment interventions has become one of the main interests of the global health community. The 'Child Survival Series' published by The Lancet is the earliest and one of the best examples (5,9-12).

The controversy over the true value of many child health interventions still rekindle debates now and then. First, once a few published randomized controlled trials show effectiveness of an intervention, it becomes unethical to scale up the evaluation only to deprive the control arm of apparent benefits. Second, the diversity of study settings and contexts produces enormous confounding and distorts generalization. Third, due to resource constraints, not every study can achieve sufficiently large simple size. Many of them eventually become underpowered, which leads to diverse and often conflicting results. Furthermore, mortality is rarely -- if ever -- an acceptable outcome of an intervention trial, and the introduction of proxy indicators creates uncertainty over the true effects on mortality and causes ambiguous conclusions. The most recent effort to integrate estimated effectiveness of interventions on child mortality has been published in 2 supplements of the *International Journal of Epidemiology* and *BMC Public Health*, providing the theoretical and methodological background information for the 'Lives Saved Tool (LiST)' (13). LiST is an evidence-based software module that allows prediction of the impact of scaling up different child health interventions at the national, regional and global level. Although this project is designed and performed to produce reasonably conservative estimates, the primary information gap is still an open issue and that new evidence from any proper sources would further refine the estimates.

One of the potential sources of this kind is academic literature in the Chinese language. The research production of Chinese academics for the past few decades, which is being published in more than nine thousands of Chinese academic periodicals, has recently been digitalized and made available in the public domain. It has been proven that strategically retrieving and analysing qualified publications in the Chinese literature contributes significant evidence and updates to the understanding and knowledge on various topics in the field of child health epidemiology (14). The aim of this study was to systematically identify and assess the evidence from Chinese literature sources on the efficacy and effectiveness of child health interventions in China.

METHODS
=======

The China National Knowledge Infrastructure (CNKI) databases were searched for the period January 1980 to March 2011. CNKI is the most complete source of academic information in China and represents the Chinese equivalent of PubMed or the Web of Knowledge (15). A systematic search of CNKI was performed to identify clinical and community-based studies with primary data reporting either efficacy or effectiveness of child health interventions relevant to neonates, infants, pre-school children or parents in China. Studies were included if: the total cohort was more than 50 subjects; the study design was prospective; the sample population was exclusively Chinese who lived in China at long-term residency base (16,17).

The search terms used were various combinations from a set of terms for 'efficacy' and 'effectiveness' in their Chinese equivalences, ie, '效果', '评价', '影响', etc. and a set of terms for each intervention in their Chinese equivalences as well, eg, '叶酸', '维生素B', '补充', etc. for 'folic acid (vitamin B) supplementation'. The first step was to search prevention and treatment interventions targeting causes of child death in general (early development- related excluded). As this search strategy aimed to be as inclusive as possible, it resulted in 6476 publications which mentioned 32 interventions ([**Table 1**](#T1){ref-type="table"}). The first level screening based on titles left 649 studies for further identification as the majority were not relevant at all to the topic of 'efficacy' or 'effectiveness'. The abstract screening then left 136 relevant records for full text retrieving. Eventually, 59 studies (up to 1% of the initial screen) for 20 interventions were retained ([**Table 2**](#T2){ref-type="table"}). The most common reasons for exclusion were: 1. the total sample cohort was less than 50 subjects, considering that the small sample size might lead to large errors; 2. study design was retrospective, which might cause massive recall bias; 3. the study method was not sufficiently described to understand or interpret the results.

###### 

List of 32 interventions chosen for the review\*

  Preventive interventions
  -----------------------------------------------------------------------------------
  • Antenatal steroids to prevent preterm birth
  • Antibiotics for premature rupture of membranes
  • Breastfeeding (exclusively for 6 mo)
  • Calcium supplementation to prevent pre-eclampsia and eclampsia
  • Clean delivery practices
  • Complementary feeding
  • Detection and management of breech births (Caesarean section)
  • Folic acid (vitamin B) supplementation
  • Hib vaccination to prevent pneumonia
  • Insecticide-treated materials
  • Intermittent presumptive treatment for malaria in pregnancy
  • Kangaroo mother care
  • Labour surveillance (including partograph) for early diagnosis of complications
  • Measles vaccination
  • Nevirapine and replacement feeding (where possible) to prevent HIV transmission
  • Newborn temperature management
  • Prevention and management of hypothermia
  • Syphilis detection and treatment
  • Tetanus toxoid (neonatal)
  • Vitamin A supplementation
  • Water, sanitation, hygiene
  • Zinc supplementation

  Treatment interventions
  --------------------------------------------------------------------
  • Antibiotics for dysentery
  • Antibiotics for neonatal sepsis
  • Anti-malarials
  • Community-based pneumonia case management, including antibiotics
  • Corticosteroids for preterm labour
  • Detection and treatment of asymptomatic bacteriuria
  • Newborn resuscitation
  • Oral rehydration therapy
  • Vitamin A
  • Zinc for treatment of diarrhoea

\*The interventions were chosen based on *Lancet*'s Child Survival Series list of interventions (5) and supplemented with any additional interventions on which at least 1 publication in Chinese literature could be found during the period 1980--2011.

###### 

The list of 59 retained studies for 20 interventions

  Preventive interventions                                                          Key search terms            General search terms        Crude hits   Title hits   Abstract hits   Final hits
  --------------------------------------------------------------------------------- --------------------------- --------------------------- ------------ ------------ --------------- ------------
  Antibiotics for premature rupture of membranes                                    抗生素;胎膜早破             效果;评价;影响;作用; 干预   309          26           2               1
  Clean delivery practices                                                          科学接生                    效果;评价;影响;作用; 干预   30           16           4               1
  Complementary feeding                                                             辅食添加; 辅食喂养          效果;评价;影响;作用; 干预   147          23           13              7
  Folic acid (vitamin B) supplementation                                            叶酸;维生素B;补充           效果;评价;影响;作用; 干预   123          21           12              2
  HiB vaccination to prevent pneumonia                                              Hib疫苗                     效果;评价;影响;作用; 干预   124          34           2               1
  Kangaroo mother care                                                              袋鼠式护理;皮肤接触护理     效果;评价;影响;作用; 干预   60           31           15              7
  Labour surveillance (including partograph) for early diagnosis of complications   产前检查; 并发症;早期诊断   效果;评价;影响;作用; 干预   366          27           6               2
  Measles vaccination                                                               麻疹疫苗                    效果;评价;影响;作用; 干预   68           21           5               2
  Nevirapine and replacement feeding (where possible) to prevent HIV transmission   奈韦拉平;替代喂?; 艾滋病    效果;评价;影响;作用; 干预   156          44           2               1
  Newborn temperature management                                                    新生儿; 温度管理            效果;评价;影响;作用; 干预   1            1            1               1
  Syphilis detection and treatment                                                  梅毒                        效果;评价;影响;作用; 干预   184          12           10              4
  Tetanus toxoid (neonatal)                                                         破伤风;类毒素;新生儿        效果;评价;影响;作用; 干预   197          9            3               2
  Vitamin A supplementation                                                         维生素A;维他命A             效果;评价;影响;作用; 干预   558          56           10              2
  Water, sanitation, hygiene                                                        水与环境卫生(WES)项目       效果;评价;影响;作用; 干预   19           8            2               1

  Treatment interventions                                                                             
  ------------------------------------ ------------------ --------------------------- ----- ---- ---- ----
  Antibiotics for dysentery            痢疾;抗生素        效果;评价;影响;作用; 干预   263   5    1    1
  Corticosteroids for preterm labour   糖皮质激素; 早产   效果;评价;影响;作用; 干预   231   12   6    1
  Newborn resuscitation                新生儿复苏         效果;评价;影响;作用; 干预   969   29   18   11
  Oral rehydration therapy             口服补液疗法       效果;评价;影响;作用; 干预   112   15   1    1
  Vitamin A                            维生素A;维他命A    效果;评价;影响;作用; 干预   138   28   2    2
  Zinc for treatment of diarrhoea      锌;腹泻;治疗       效果;评价;影响;作用; 干预   170   39   12   11

RESULTS
=======

The distribution of the 59 included studies clustered mainly in the eastern and central regions of China ([**Figure 1**](#F1){ref-type="fig"}). The latest classification of Chinese regions based on regional macro-economy development recommended dividing China into the eastern, central and western regions. Of the three macro-regions, Western China suffered the most from economical disadvantages. This also provides insight into a further discrepancy: the retained studies conducted in Eastern and Central China were generally led by major university-affiliated hospitals, which were in control of the key resources, such as the provincially leading research and teaching hubs and/or networks. In Western China, however, the retained studies were mostly conducted through cooperation with international organizations, as the overseas aid programmes. Also, an analysis of the period 1980 to 2011, which separated the included studies into 4-year time-periods by frequency, showed the time trend of a steady increase until the period 2004--2007. This was followed by a sharp drop during the period 2008--2011, to the level of activity observed back in 1992--1995 ([**Figure 2**](#F2){ref-type="fig"}).

![Geographical distribution of 59 retained studies during 1980--2011.](jogh-01-087-F1){#F1}
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All the included studies that evaluated a total of 20 interventions were focused on addressing efficacy or effectiveness as the primary outcome. Among preventive interventions (14 interventions), most studies were dedicated to complementary feeding (7 studies), kangaroo mother care (7 studies) and syphilis detection and treatment (4 studies) ([**Table 3**](#T3){ref-type="table"}). Among treatment interventions (6 interventions), the most frequently studied were zinc for treatment of diarrhoea (11 studies) and newborn resuscitation (9 studies) ([**Table 4**](#T4){ref-type="table"}). Within each intervention, the results from individual studies generally supported each other, providing evidence on the positive effects for all interventions. However, several peculiarities need to be noted: for complementary feeding, each study adopted different food formulas and this may be due to the widespread geographic distribution. For Kangaroo mother care, the research interests varied dramatically, which made the targeting outcomes very diverse -- including body temperature management, pain management, weigh gain, physiological and behavioural factors, etc. For syphilis detection and treatment, it was notable that one community-based study conducted in Guangdong province and recruiting 186 517 subjects reported an impressive 61.90% reduction rate during a period of two years. For zinc for treatment of diarrhoea, although OER and anti-diarrhoea duration were common indicators, the ingredients and portions of zinc formula adopted in each study were not consistent. Finally, for newborn resuscitation the universal outcome indicators employed in each study were Apgar-5 and Apgar-10, while Apgar-1 and Apgar-7 occasionally reported with other specific outcomes such as mortality, morbidity of asphyxia, pneumonia and infections.

###### 

Three most investigated preventive child health interventions in Chinese literature

  Study No   Year         Province    Cohort site   Cohort No.   Sample size (Intervention1)   Sample size (Intervention2)   Sample size (Controls)   Outcome                                  Indicators of the outcome                                                                                                                                           
  ---------- ------------ ----------- ------------- ------------ ----------------------------- ----------------------------- ------------------------ ---------------------------------------- ----------------------------------------------------------------------------------- -------------------------------------------------------------------------- ---- ----
  1          2009         Zhejiang    Hospital      --           100                           --                            100                      Body temperature management              Temperature recovery speed (hr): I = 1.665 ± 1.36, C = 6.635 ± 3.838, *P* \< 0.05   --                                                                         --   --
  2          2008--2009   Guangdong   Hospital      --           50                            --                            50                       Venepuncture pain management             Heart rates (/min): I\<C, (8-14), *P* \< 0.05                                       Blood oxygen rate (%): I\<C, (1-5), *P *\< 0.05                            --   --
  3          2007         Hebei       Hospital      --           80                            --                            80                       Body temperature management              Temperature recovery speed: I = 38(\<4h), C = 18(\<4h), *P* \< 0.05                 --                                                                         --   --
  4          2007--2008   Guangdong   Hospital      --           30                            --                            30                       Weight gain                              Weight gain in the 28th day: I = 835g, C = 750g, *P* \< 0.0005                      --                                                                         --   --
  5          2006--2008   Hunan       Hospital      --           60                            --                            60                       Physiological and behaviour indicators   Heart rates (/min): I = 142.4 ± 19.1, C = 157.1 ± 24.8, *P* \< 0.01                 Blood oxygen rate (%): I = 91.7 ± 4.6, C = 87.9 ± 9.1, *P* \< 0.01         --   --
  6          2004--2009   Shanxi      Hospital      --           55                            --                            53                       Pain management                          Heart rates (/min): I = 152.77 ± 15.98, C = 162.34 ± 22.02, *P* \< 0.05             Blood oxygen rate (%): I = 94.03 ± 10.89, C = 93.08 ± 10.62, *P* \< 0.05   --   --
  7          1999--2002   Guangdong   Hospital      --           54                            --                            50                       Prognosis of very LBW                    MDI: I = 99 ± 12, C = 89 ± 10, *P* \< 0.01                                          PDI:, I = 91 ± 10 C = 83 ± 11, *P* \< 0.05                                 --   --

  • Complementary feeding                                                                                                                                                                                    
  ------------------------- ------------ ----------- ----------- ---- ------ ----- ----- ---- ------------------------------------------------------------ -------------------------------------------- ---- ----
  1                         2007--2008   Guangxi     Community   --   100    --    100   --   Percentage-Nutrition (P0-P100): I\>C, *P* \< 0.05            --                                           --   --
  2                         2006--2008   Jiangsu     Hospital    --   206    --    175   --   Hb (g/L): I = 80.74 ± 13.24 C = 66.43 ± 12.57, *P* \< 0.05   IDA: I = 9(4.5%) C = 33(19.4), *P* \< 0.05   --   --
  3                         2004         Gansu       Community   --   1000   500   127   --   DQ: I\>C, *P* \< 0.0001                                      --                                           --   --
  4                         2003         Guangdong   Hospital    --   251    --    237   --   Malnutrition: I = 9, C = 42, *P* \< 0.01                     --                                           --   --
  5                         2002         Jiangsu     Hospital    --   52     --    52    --   Anaemia(%): I = 17.31, C = 38.46, *P* \< 0.05                --                                           --   --
  6                         1997         Liaoning    Hospital    --   107    --    34    --   Standard BW: I = 64(87.7), C = 21(61.8), *P* \< 0.01         --                                           --   --
  7                         1994         Sichuan     Hospital    --   45     60    58    --   BW, Height, HC: I\>C, *P* \< 0.05                            --                                           --   --

  • Syphilis detection and treatment                                                                                                                                                                        
  ------------------------------------ ------------ ---------------- ----------- -------- ----- ---- ---- ---- ---------------------------------------------------------------------------------- ---- ---- ----
  1                                    2006--2009   Inner Mongolia   Hospital    --       168   --   32   --   Syphilis(+): 72 children born to Interventions; 19 children born to Controls       --   --   --
  2                                    2005         Guangdong        Community   159017   --    --   --   --   125(syphilis child cases in theory for 2005) -- 4 (syphilis child cases in 2005)   --   --   --
  3                                    2001--2005   Guangdong        Hospital    --       50    --   13   --   Syphilis(+): 8 children born to Interventions; 10 children born to Controls        --   --   --
  4                                    2001--2002   Guangdong        Community   186517   --    --   --   --   Reduction: 61.90%                                                                  --   --   --

I -- interventions, C -- controls, LBW -- low birth weight, MDI -- mental developmental index, PDI -- psychomotor developmental index, Hb -- hemoglobin concentration, IDA -- iron deficiency anaemia, DQ -- developmental quotient, BW -- birth weight, HC -- head circumference

###### 

Two most investigated treatment child health interventions in Chinese literature

  Study No   Year         Province             Cohort site   Cohort No.   Sample size (Intervention1)   Sample size (Intervention2)   Sample size (Controls)   Outcome                                      Indicators of the outcome                                                                                                                                              
  ---------- ------------ -------------------- ------------- ------------ ----------------------------- ----------------------------- ------------------------ -------------------------------------------- ------------------------------------------------------------------------------- --------------------------------------------------------------------------------- ---- ----
  1          2009         Shandong             Hospital      --           65                            --                            60                       --                                           OER (%): I = 96.92, C = 78.33, *P* \< 0.05                                      Anti-diarrhoea duration (days): I = 6 ± 1.05, C = 7 ± 1.02, *P* \< 0.05           --   --
  2          2008--2009   Jiangxi              Hospital      --           90                            --                            90                       --                                           OER (%): I = 90.0, C = 60.0, *P* \< 0.05                                        Anti-diarrhoea duration (days): I = 3.11 ± 2.41, C = 5.32 ± 2.11, *P* \< 0.01     --   --
  3          2008--2009   Tianjing             Hospital      --           45                            --                            42                       --                                           OER (%): I = 86.3, C = 76.2, *P* \< 0.05                                        --                                                                                --   --
  4          2008--2009   Liaoning             Hospital      --           55                            --                            55                       --                                           OER (%): I = 89.09, C = 65.45, *P* \< 0.01                                      --                                                                                --   --
  5          2007--2009   Shaanxi              Hospital      --           40                            --                            40                       --                                           OER (%): I = 92.5, C = 80.0, *P* \< 0.05                                        Anti-diarrhoea duration (days): I = 2.81 ± 0.83, C = 4.21 ± 1.98, *P* \< 0.01     --   --
  6          2007--2009   Sichuan              Hospital      --           120                           --                            120                      --                                           OER (%): I = 93.4, C = 82.5, *P* \< 0.05                                        --                                                                                --   --
  7          2007--2009   Jiangxi              Hospital      --           60                            --                            60                       --                                           OER (%): I = 93.4, C = 73.2, *P* \< 0.01                                        Anti-diarrhoea duration (hrs): I = 48.92 ± 3.02, C = 100.23 ± 3.16, *P* \< 0.05   --   --
  8          2007         Hubei                Hospital      --           55                            --                            50                       --                                           Anti-diarrhoea duration (hrs): I = 43 ± 6, C = 49 ± 5, *P* \< 0.01              --                                                                                --   --
  9          2006--2008   Chongqing Hospital   --            164          --                            168                           --                       OER (%): I = 92.07, C = 74.41, *P* \< 0.01   Anti-diarrhoea duration (days): I = 3.11 ± 1.41, C = 4.07 ± 2.12, *P* \< 0.01   --                                                                                --   
  10         2005--2007   Sichuan              Hospital      --           95                            --                            91                       --                                           OER (%): I\>CP; \<0.01                                                          --                                                                                --   --
  11         2005--2006   Shandong             Hospital      --           124                           --                            126                      --                                           OER (%): I = 98, C = 92, *P* \< 0.05                                            --                                                                                --   --

  • Newborn resuscitation                                                                                                                                                                                                                                
  ------------------------- ------------ ---------- ---------- ---- ------- ---- ------ ---- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------- -------------------------------------
  1                         2003--2006   Shandong   Hospital   --   3050    --   2850   --   Asphyxia (%): I = 0.4, C = 2.1, *P* \< 0.01           --                                                    --                                              --
  2                         2002--2005   Qinghai    Hospital   --   682     --   1318   --   Mortality (%): I = 15, C = 38, *P* \< 0.05            --                                                    --                                              --
  3                         2001--2006   Hubei      Hospital   --   13905   --   7808   --   Asphyxia (%): I = 0.48, C = 2.7, *P* \< 0.01          --                                                    --                                              --
  4                         2000--2003   Henan      Hospital   --   168     --   55     --   Apgar-5: I = 8.0 ± 1.0, C = 6.3 ± 0.8, *P* \< 0.01    Apgar-10: I = 9.0 ± 1.1, C = 8.0 ± 0.5, *P* \< 0.01   --                                              --
  5                         1999         Anhui      Hospital   --   143     --   143    --   Apgar-7: I = 3.4, C = 12.5, *P* \< 0.05               Pneumonia (%): I = 1.3, C = 6.9, *P* \< 0.05          Infections (%): I = 1.3, C = 6.2, *P* \< 0.05   --
  6                         1997--2000   Sichuan    Hospital   --   52      --   56     --   Pneumonia: I = 9, C = 2, *P* \< 0.05                  HIE: I = 9, C = 1, *P* \< 0.05                        Apgar-5: I = 46, C = 50, *P* \< 0.05            Apgar-10: I = 50,C = 52 *P* \< 0.05
  7                         1997--1998   Jilin      Hospital   --   2478    --   782    --   Asphyxia (%): I = 5.29, C = 15.22, *P* \< 0.01        --                                                    --                                              --
  8                         1993--1997   Shandong   Hospital   --   54      --   63     --   Survival rate (%): I = 100, C = 90.47, *P* \< 0.005   --                                                    --                                              --
  9                         1989, 1997   Shaanxi    Hospital   --   1349    --   2414   --   Asphyxia (%): I = 2.3, C = 4.4, *P* \< 0.05           Apgar-1: I = 6.1, C = 3.7, *P* \< 0.01                Apgar-5: I = 9.7, C = 7.7, *P* \< 0.01          --

I -- interventions, C -- controls, OER -- overall effect rate, HIE -- hypoxic ischemic encephalopathy

The evidence on efficacy or effectiveness of the 32 interventions conducted in Chinese children in the Chinese literature was either of comparable quality, or more informative than the available reports on China in the English literature ([**Table 5**](#T5){ref-type="table"}). Although the selected English literature sources showed a substantial and strikingly increasing number of publications on child health interventions during the same period, studies on intervention effectiveness exclusively in Chinese children were very rarely published, and the few rare studies were unlikely to scale-up a systematic analysis or meta-analysis for any of the 32 selected interventions in this paper.

###### 

The remaining 15 child health interventions with addressed effectiveness in Chinese literature

  PREVENTIVE INTERVENTIONS                                                                                                                                                                                    
  -------------------------- ------------ ---------- ----------- ---- -------- ---- ---- -------- --------------------------- --------------------------------------------------------------------- ---- ---- ----
  1                          1996-1997    Zhejiang   Hospital    --   2265     --   --   2265     Congenital heart diseases   RR = 1.77(95%CI: 1.082--2.466); AR = 1.29% ARP = 43.63% *P* \< 0.01   --   --   --
  2                          1993--1995   National   Community   --   130142   --   --   117689   NTD                         120(NTDs)/130142 137(NTDs)/117689 *P* \< 0.01                         --   --   --

  • Tetanus toxoid (neonatal)                                                                                                                                                                                                
  ----------------------------- ------------ --------- ----------- ---- ----- ---- ---- ----------- ---- --------------------------------------------------------------------------------------------------------- ---- ---- ----
  1                             1991--1993   Hunan     Community   --   170   --   --   170(self)   --   IU/ml(mothers) increased = 0.137--0.008 IU/ml(children) = 0.054 *P* \< 0.01                               --   --   --
  2                             1986--1987   Ningxia   Community   --   67    --   --   41          --   IU/ml \>0.01: 89.55% of children born to Interventions; 14.63% of children born to Controls *P* \< 0.01   --   --   --

  • Antibiotics for premature rupture of membranes                                                                                                                                                                                                                                              
  -------------------------------------------------- ------------ ------- ---------- ---- ---- ---- ---- ---- ---- -------------------------------------- ------------------------------------------ ------------------------------------------------------------------------------------------ ---------------------------------
  1                                                  1992--1997   Henan   Hospital   --   30   --   --   30   --   BW: I = 2580g; C = 2391g *P* \< 0.01   1 min Apgar ≤7: I = 4; C = 9 *P* \< 0.01   Infections: I = 5; C = 7, *P* \< 0.01 Intracranial haemorrhage: I = 5; C = 5 *P* \< 0.01   Death: I = 0; C = 2 *P* \< 0.01

  • Labour surveillance (including partograph) for early diagnosis of complications                                                                                                                                                                                           
  ----------------------------------------------------------------------------------- ------------ ---------- ---------- ---- ------- ---- ---- ------ ---- ---------------------------------- ---------------------------------- ------------------------------------------- -----------------------------------------------------
  1                                                                                   2006--2008   Zhejiang   Hospital   --   11186   --   --   1066   --   RDS: I = 290; C = 52 *P* \< 0.01   LBW: I = 551; C = 88 *P* \< 0.01   Preterm birth:I = 554; C = 95 *P* \< 0.01   Caesarean section rate: I = 68; C = 113 *P* \< 0.01
  2                                                                                   2006--2007   Shandong   Hospital   --   226     --   --   208    --                                                                                                                     

  • Clean delivery practices                                                                                                                                 
  ---------------------------- ------------ -------------- ---------- ---- ----- ---- ---- ----- ---- -------------------------------------------- ---- ---- ----
  1                            1991--1993   Heilongjiang   Hospital   --   355   --   --   366   --   Death (Children): I = 9; C = 5 *P* \< 0.01   --   --   --

  • Newborn temperature management                                                                                                                              
  ---------------------------------- ------------ ------- ---------- ---- ----- ---- ---- ------ ---- ----------------------------------------------- ---- ---- ----
  1                                  2002--2003   Gansu   Hospital   --   715   --   --   1096   --   neonatal sclerodema: I = 3 C = 10 *P* \< 0.01   --   --   --

  • Hib vaccination to prevent pneumonia                                                                                                                    
  ---------------------------------------- ------ ---------- ----------- ---- ----- ---- ---- ----- ---- ---------------------------------------- ---- ---- ----
  1                                        2006   Shanghai   Community   --   372   \-   \-   305   --   Hib+ (%): I = 9.8; C = 3.8 *P* \< 0.01   --   --   --

  • Water, sanitation, hygiene                                                                                                                                                                                                        
  ------------------------------ ------------ ------- ----------- ------------- ---- ---- ---- ---- ---- ------------------------------------------------------------------------------------------------------------------ ---- ---- ----
  1                              1996--2000   Gansu   Community   21 villages   --   --   --   --   --   Sanitation per household, population educated, children hygiene behaviour positive change rate are all increased   --   --   --

  • Vitamin A supplementation                                                                                                                                             
  ----------------------------- ------------ ----------- ----------- ---- ----- ---- ---- ----- ---- ---------------------------------------------------------- ---- ---- ----
  1                             2001--2005   Chongqing   Institute   --   64    --   --   61    --   Hb (g/L): I = 122.0 ± 7.5; C = 120.3 ± 7.87 *P* \< 0.001   --   --   --
  2                             1991--1992   Hebei       Community   --   327   --   --   343   --   Z value:I\>C *P* \< 0.01                                   --   --   --

  • Nevirapine and replacement feeding (where possible) to prevent HIV transmission                                                                                         
  ----------------------------------------------------------------------------------- ------ -------- ----------- ---- ---- ---- ---- ---- ---- ----------------- ---- ---- ----
  1                                                                                   2005   Yunnan   Community   --   61   61   \-   \-   \-   Reduction: 7.0%   --   --   --

  • Measles vaccination                                                                                                                                                     
  ----------------------- ------------ --------- ----------- ------- ---- ---- ---- ---- ---- ------------------------------------------------------------------- ---- ---- ----
  1                       2000--2007   Guizhou   Community   25302   --   --   --   --   --   Morbidity: 26.68/100000(2002) 3.52/100000(2003) 0.20/100000(2007)   --   --   --
  2                       1991         Hubei     Community   503     --   --   --   --   --   Reduction in 6 y: 59.22%                                            --   --   --

  TREATMENT INTERVENTIONS                                                                                                                                         
  ------------------------- ------ ------- ---------- ---- ---- ---- ---- ---- --- -------------------------------------------------------------------- ---- ---- ----
  1                         2000   Anhui   Hospital   --   --   18   19   --   5   Hyaline membrane disease (\<34 weeks gestation): I\<C *P* \< 0.001   --   --   --

  • Oral rehydration therapy                                                                                                                                                                                                                                                                                                                     
  ---------------------------- ------------ -------------- ---------- ---- ---- ---- ---- ---- ---- -------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------- ----
  1                            2001--2005   Heilongjiang   Hospital   --   60   --   --   60   --   Temperature recovery speed (days): I = 1.51 ± 0.89;C = 3.87 ± 2.03 *P* \< 0.01   Diarrhoea recovery speed (days): I = 2.97 ± 1.45;C = 5.72 ± 2.43 *P* \< 0.01   General recovery speed (days): I = 4.70 ± 1.98;C = 7.28 ± 2.86 *P* \< 0.01   --

  • Antibiotics for dysentery                                                                                                                                                                            
  ----------------------------- ------------ --------- ---------- ---- ---- ---- ---- ---- ---- ---------------------------------------------------------------------------------------------- ---- ---- ----
  1                             1994--1996   Jiangsu   Hospital   --   24   30   23   --   --   2 preferred based on temperature recovery speed and anti--diarrhoea duration: Both Ps \<0.01   --   --   --

  • Vitamin A                                                                                                                                                                                                                                                                                                                                       
  ------------- ------------ ----------- ---------- ---- ---- ---- ---- ---- ---------------------------------- ----------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------------------------------------------------------------------------- -----------------------------------------------------
  1             2003--2006   Jiangxi     Hospital   --   42   --   --   35   Recurrent respiratory infections   Temperature recovery speed (days): I = 3.5; C = 6.0 *P* \< 0.01   Diarrhoea recovery duration (days): I = 5; C = 8 *P* \< 0.01                   Diarrhoea recovery duration (days): I = 5; C = 8 *P* \< 0.01                       Recurrence (%): Interventions\<Controls *P* \< 0.05
  2             1990--2000   Chongqing   Hospital   --   30   --   --   30   Measles                            VA (µmol/L): I = 1.17 ± 0.12; C = 0.84 ± 0.24 *P* \< 0.01         Cough recovery duration (days): I = 8.12 ± 1.24: C = 9.36 ± 1.68 *P* \< 0.01   Diarrhoea recovery duration (days): I = 7.88 ± 1.87; C = 9.13 ± 1.20 *P* \< 0.01   Complications (%) Interventions\<Controls Ps \<0.05

I -- intervention, C -- control, RR -- risk ratio, AR -- attribute ratio, ARP -- attribute ratio percentage, RDS -- respiratory distress syndrome, Hb -- hemoglobin concentration

DISCUSSION
==========

This paper represents the very first attempt to systematically investigate the accessibility, quantity and quality of the research production of Chinese academics over the period of the past 30 years on efficacy and effectiveness of child health interventions in China. It is possible that a parallel review and/or the extended systematic review of other digital Chinese-language databases such as Chongqing VIP and Wanfang would have identified slightly more studies. However, the initial searching within the two additional databases did not seem to add any further evidence (my search on February 15, 2011), and this might due to the extremely massive overlap in indexed journals of the three domains (15,18,19). It is very unlikely that substantial omissions could have drawn dramatically different conclusions on quantity assessment from those that this paper offers.

Conducting studies which evaluate interventions generally not only requires substantial financial support and high-level technical expertise, but it is also subject to various vital factors, such as ethical approval, unique local conditions/customs and liaisons with multiple organizations, to name a few. Usually, a single team of researchers has to invest tremendous efforts to ensure smooth workflow for years to achieve the ultimate outcome, either positive or negative, even possessing sufficient essential resources. This may explain why, in the global context, the research production on intervention evaluation is relatively scarce and the relevant studies with large sample sizes and robust study designs are extremely valuable.

According to GRADE criteria, the retained studies in the Chinese literature are generally of modest quality (17). Relatively small sample sizes and wide confidence intervals make it unjustified that all retained studies should be expected to show positive effects of the investigated interventions, implying a likely publication bias. This has not ridden the Chinese literature only, as there is a traditional academic and industrial resistance to reporting and pursuing publication of negative effects, especially where the previous evaluation showed benefits. China may consider incorporating the existing national ethics approval system with a mandatory national trail registration system in order to keep all the trails conducted in China well tracked and ensure that the final outcomes are reported and made public.

Despite insufficient information to fully assess the current situation of child health interventions in depth in China, the urban-rural discrepancy in study distribution and funding resources is particularly notable. While the studies in Eastern and Central China were conducted by regional leading institutes as scientific research projects, Western China, the most remote and mountainous region of the country, seems to still be reliant on overseas aid to implement child health interventions. The longstanding urban-rural socio-economical imbalance results in limited academic and industrial activities focusing on the most underdeveloped region of China, where implementing, evaluating and further developing appropriately customized interventions may achieve highest potential impact on child mortality reduction and other aspects of child health in China as a whole.

Comprehensive and accurate data and evidence on child health interventions are indispensable for prioritizing prevention and treatment strategies in order to achieve optimal policy decisions. It is clear that considerable research interests and initiatives from both inside and outside the country have been concentrating on child health interventions, especially preventive interventions in China. How to best harness and facilitate those potential strengths in this still new and fast growing field could be the next opportunity and challenge that the country has to take.
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